Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: A systematic review and network meta-analysis

Triple-negative breast cancer (TNBC) is a life-threatening subtype of breast cancer with limited treatment options. Therefore, this network meta-analysis (NMA) aimed to evaluate and compare the effect of various neoadjuvant chemotherapy (NCT) options on the long-term survival of patients with TNBC.